Anthropic Releases New 'Mythos-Class' Model to General Public With Guardrails
Anthropic Releases New 'Mythos-Class' Model to General Public With Guardrails
Queries about dangerous topics such as cybersecurity or bioweapons will be steered to an older Opus model.
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are under FDA review for approval this year.
J.M. Smucker Expects Sales to Fall This Year
Pharmalittle: We're reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
Anthropic发布不具备执行网络安全任务能力的Mythos模型-36氪
Gilead and Merck's latest trial success and flop
Anthropic releases Mythos-like AI model to the public two months after private rollout rocked Wall Street
Anthropic releases ‘too dangerous’ AI Model with safeguards in place
Anthropic’s Mythos Is Coming Today; Apple Pursues Modest Goals with Siri Revamp
Anthropic Releases New 'Mythos-Class' Model to General Public With Guardrails
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
